ADIPOQ and type 2 diabetes mellitus: Indeed, adiponectin levels have been reported to be reduced in patients presenting type 2 diabetes or metabolic syndrome, and low plasma adiponectin concentrations closely correlate with obesity-related diseases such as atherosclerotic cardiovascular diseases [3, 21].